Spots Global Cancer Trial Database for rad001 (everolimus)
Every month we try and update this database with for rad001 (everolimus) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer | NCT01231659 | Postmenopausal ... Locally Advance... Metastatic Brea... | Everolimus Letrozole | 18 Years - | Novartis | |
| Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer | NCT00374140 | Small Cell Lung... | RAD001 (everoli... | 18 Years - | University of Pittsburgh | |
| RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line Treatment | NCT00729482 | Stomach Neoplas... | RAD001 | 18 Years - 75 Years | Asan Medical Center | |
| Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors | NCT00423865 | Unspecified Adu... | cisplatin everolimus gene expression... immunohistochem... laboratory biom... pharmacological... biopsy | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular Targets | NCT01226056 | Advanced Solid ... | RAD001 in combi... | 18 Years - | Southern Europe New Drug Organization | |
| Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer | NCT01068249 | Endometrial Can... | Letrozole RAD001 (Everoli... | 18 Years - | M.D. Anderson Cancer Center | |
| Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) | NCT01642186 | Fibrolamellar C... Fibrolamellar L... | everolimus letrozole plus ... combination of ... | 12 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) | NCT01642186 | Fibrolamellar C... Fibrolamellar L... | everolimus letrozole plus ... combination of ... | 12 Years - | Memorial Sloan Kettering Cancer Center | |
| RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas | NCT01198665 | Peripheral T Ce... Anaplastic Larg... Angioimmunoblas... Cutaneous T Cel... | RAD001 (Everoli... | 20 Years - 70 Years | Samsung Medical Center | |
| Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer | NCT00374140 | Small Cell Lung... | RAD001 (everoli... | 18 Years - | University of Pittsburgh | |
| RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma | NCT01252251 | Uveal Melanoma | RAD001 (Everoli... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis | NCT00449748 | Systemic Mastoc... | RAD001 (Everoli... | 18 Years - | M.D. Anderson Cancer Center | |
| Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer | NCT01231659 | Postmenopausal ... Locally Advance... Metastatic Brea... | Everolimus Letrozole | 18 Years - | Novartis | |
| Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies | NCT01182168 | Bladder Cancer Renal Pelvis Ca... Ureter Cancer | gemcitabine and... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer | NCT01068249 | Endometrial Can... | Letrozole RAD001 (Everoli... | 18 Years - | M.D. Anderson Cancer Center | |
| Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis | NCT00449748 | Systemic Mastoc... | RAD001 (Everoli... | 18 Years - | M.D. Anderson Cancer Center | |
| Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas | NCT01158651 | Glioma | RAD001 (Everoli... | 1 Year - 21 Years | University of Alabama at Birmingham |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
